Pharma & Healthcare
Global Human Coagulation Factor Ⅷ Market Research Report 2025
- Sep 09, 25
- ID: 136054
- Pages: 83
- Figures: 87
- Views: 22
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor Ⅷ, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor Ⅷ.
The Human Coagulation Factor Ⅷ market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Coagulation Factor Ⅷ market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor Ⅷ companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
CSL Behring
Baxter
Grifols
Octapharma
Pfizer
Taibang Bio
Shanghai Laishi
Hualan Bio
Guangdong Shuanglin
GreenCross
Pfizer
Segment by Type
Recombinant Factor VIII
Human Factor VIII
Segment by Application
Hemophilia A
Relvent Bleeding Diseases
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Coagulation Factor Ⅷ company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Human Coagulation Factor Ⅷ market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Coagulation Factor Ⅷ market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor Ⅷ companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
CSL Behring
Baxter
Grifols
Octapharma
Pfizer
Taibang Bio
Shanghai Laishi
Hualan Bio
Guangdong Shuanglin
GreenCross
Pfizer
Segment by Type
Recombinant Factor VIII
Human Factor VIII
Segment by Application
Hemophilia A
Relvent Bleeding Diseases
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Coagulation Factor Ⅷ company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Recombinant Factor VIII
1.2.3 Human Factor VIII
1.3 Market by Application
1.3.1 Global Human Coagulation Factor Ⅷ Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hemophilia A
1.3.3 Relvent Bleeding Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Coagulation Factor Ⅷ Market Perspective (2020-2031)
2.2 Global Human Coagulation Factor Ⅷ Growth Trends by Region
2.2.1 Global Human Coagulation Factor Ⅷ Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human Coagulation Factor Ⅷ Historic Market Size by Region (2020-2025)
2.2.3 Human Coagulation Factor Ⅷ Forecasted Market Size by Region (2026-2031)
2.3 Human Coagulation Factor Ⅷ Market Dynamics
2.3.1 Human Coagulation Factor Ⅷ Industry Trends
2.3.2 Human Coagulation Factor Ⅷ Market Drivers
2.3.3 Human Coagulation Factor Ⅷ Market Challenges
2.3.4 Human Coagulation Factor Ⅷ Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Coagulation Factor Ⅷ Players by Revenue
3.1.1 Global Top Human Coagulation Factor Ⅷ Players by Revenue (2020-2025)
3.1.2 Global Human Coagulation Factor Ⅷ Revenue Market Share by Players (2020-2025)
3.2 Global Human Coagulation Factor Ⅷ Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Coagulation Factor Ⅷ Revenue
3.4 Global Human Coagulation Factor Ⅷ Market Concentration Ratio
3.4.1 Global Human Coagulation Factor Ⅷ Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Coagulation Factor Ⅷ Revenue in 2024
3.5 Global Key Players of Human Coagulation Factor Ⅷ Head office and Area Served
3.6 Global Key Players of Human Coagulation Factor Ⅷ, Product and Application
3.7 Global Key Players of Human Coagulation Factor Ⅷ, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Coagulation Factor Ⅷ Breakdown Data by Type
4.1 Global Human Coagulation Factor Ⅷ Historic Market Size by Type (2020-2025)
4.2 Global Human Coagulation Factor Ⅷ Forecasted Market Size by Type (2026-2031)
5 Human Coagulation Factor Ⅷ Breakdown Data by Application
5.1 Global Human Coagulation Factor Ⅷ Historic Market Size by Application (2020-2025)
5.2 Global Human Coagulation Factor Ⅷ Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human Coagulation Factor Ⅷ Market Size (2020-2031)
6.2 North America Human Coagulation Factor Ⅷ Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human Coagulation Factor Ⅷ Market Size by Country (2020-2025)
6.4 North America Human Coagulation Factor Ⅷ Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Coagulation Factor Ⅷ Market Size (2020-2031)
7.2 Europe Human Coagulation Factor Ⅷ Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human Coagulation Factor Ⅷ Market Size by Country (2020-2025)
7.4 Europe Human Coagulation Factor Ⅷ Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Coagulation Factor Ⅷ Market Size (2020-2031)
8.2 Asia-Pacific Human Coagulation Factor Ⅷ Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region (2020-2025)
8.4 Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Coagulation Factor Ⅷ Market Size (2020-2031)
9.2 Latin America Human Coagulation Factor Ⅷ Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human Coagulation Factor Ⅷ Market Size by Country (2020-2025)
9.4 Latin America Human Coagulation Factor Ⅷ Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Coagulation Factor Ⅷ Market Size (2020-2031)
10.2 Middle East & Africa Human Coagulation Factor Ⅷ Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country (2020-2025)
10.4 Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Human Coagulation Factor Ⅷ Introduction
11.1.4 Bayer Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.1.5 Bayer Recent Development
11.2 CSL Behring
11.2.1 CSL Behring Company Details
11.2.2 CSL Behring Business Overview
11.2.3 CSL Behring Human Coagulation Factor Ⅷ Introduction
11.2.4 CSL Behring Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.2.5 CSL Behring Recent Development
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter Human Coagulation Factor Ⅷ Introduction
11.3.4 Baxter Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.3.5 Baxter Recent Development
11.4 Grifols
11.4.1 Grifols Company Details
11.4.2 Grifols Business Overview
11.4.3 Grifols Human Coagulation Factor Ⅷ Introduction
11.4.4 Grifols Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.4.5 Grifols Recent Development
11.5 Octapharma
11.5.1 Octapharma Company Details
11.5.2 Octapharma Business Overview
11.5.3 Octapharma Human Coagulation Factor Ⅷ Introduction
11.5.4 Octapharma Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.5.5 Octapharma Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Human Coagulation Factor Ⅷ Introduction
11.6.4 Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.6.5 Pfizer Recent Development
11.7 Taibang Bio
11.7.1 Taibang Bio Company Details
11.7.2 Taibang Bio Business Overview
11.7.3 Taibang Bio Human Coagulation Factor Ⅷ Introduction
11.7.4 Taibang Bio Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.7.5 Taibang Bio Recent Development
11.8 Shanghai Laishi
11.8.1 Shanghai Laishi Company Details
11.8.2 Shanghai Laishi Business Overview
11.8.3 Shanghai Laishi Human Coagulation Factor Ⅷ Introduction
11.8.4 Shanghai Laishi Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.8.5 Shanghai Laishi Recent Development
11.9 Hualan Bio
11.9.1 Hualan Bio Company Details
11.9.2 Hualan Bio Business Overview
11.9.3 Hualan Bio Human Coagulation Factor Ⅷ Introduction
11.9.4 Hualan Bio Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.9.5 Hualan Bio Recent Development
11.10 Guangdong Shuanglin
11.10.1 Guangdong Shuanglin Company Details
11.10.2 Guangdong Shuanglin Business Overview
11.10.3 Guangdong Shuanglin Human Coagulation Factor Ⅷ Introduction
11.10.4 Guangdong Shuanglin Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.10.5 Guangdong Shuanglin Recent Development
11.11 GreenCross
11.11.1 GreenCross Company Details
11.11.2 GreenCross Business Overview
11.11.3 GreenCross Human Coagulation Factor Ⅷ Introduction
11.11.4 GreenCross Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.11.5 GreenCross Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Human Coagulation Factor Ⅷ Introduction
11.12.4 Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.12.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Recombinant Factor VIII
1.2.3 Human Factor VIII
1.3 Market by Application
1.3.1 Global Human Coagulation Factor Ⅷ Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hemophilia A
1.3.3 Relvent Bleeding Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Coagulation Factor Ⅷ Market Perspective (2020-2031)
2.2 Global Human Coagulation Factor Ⅷ Growth Trends by Region
2.2.1 Global Human Coagulation Factor Ⅷ Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human Coagulation Factor Ⅷ Historic Market Size by Region (2020-2025)
2.2.3 Human Coagulation Factor Ⅷ Forecasted Market Size by Region (2026-2031)
2.3 Human Coagulation Factor Ⅷ Market Dynamics
2.3.1 Human Coagulation Factor Ⅷ Industry Trends
2.3.2 Human Coagulation Factor Ⅷ Market Drivers
2.3.3 Human Coagulation Factor Ⅷ Market Challenges
2.3.4 Human Coagulation Factor Ⅷ Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Coagulation Factor Ⅷ Players by Revenue
3.1.1 Global Top Human Coagulation Factor Ⅷ Players by Revenue (2020-2025)
3.1.2 Global Human Coagulation Factor Ⅷ Revenue Market Share by Players (2020-2025)
3.2 Global Human Coagulation Factor Ⅷ Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Coagulation Factor Ⅷ Revenue
3.4 Global Human Coagulation Factor Ⅷ Market Concentration Ratio
3.4.1 Global Human Coagulation Factor Ⅷ Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Coagulation Factor Ⅷ Revenue in 2024
3.5 Global Key Players of Human Coagulation Factor Ⅷ Head office and Area Served
3.6 Global Key Players of Human Coagulation Factor Ⅷ, Product and Application
3.7 Global Key Players of Human Coagulation Factor Ⅷ, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Coagulation Factor Ⅷ Breakdown Data by Type
4.1 Global Human Coagulation Factor Ⅷ Historic Market Size by Type (2020-2025)
4.2 Global Human Coagulation Factor Ⅷ Forecasted Market Size by Type (2026-2031)
5 Human Coagulation Factor Ⅷ Breakdown Data by Application
5.1 Global Human Coagulation Factor Ⅷ Historic Market Size by Application (2020-2025)
5.2 Global Human Coagulation Factor Ⅷ Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human Coagulation Factor Ⅷ Market Size (2020-2031)
6.2 North America Human Coagulation Factor Ⅷ Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human Coagulation Factor Ⅷ Market Size by Country (2020-2025)
6.4 North America Human Coagulation Factor Ⅷ Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Coagulation Factor Ⅷ Market Size (2020-2031)
7.2 Europe Human Coagulation Factor Ⅷ Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human Coagulation Factor Ⅷ Market Size by Country (2020-2025)
7.4 Europe Human Coagulation Factor Ⅷ Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Coagulation Factor Ⅷ Market Size (2020-2031)
8.2 Asia-Pacific Human Coagulation Factor Ⅷ Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region (2020-2025)
8.4 Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Coagulation Factor Ⅷ Market Size (2020-2031)
9.2 Latin America Human Coagulation Factor Ⅷ Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human Coagulation Factor Ⅷ Market Size by Country (2020-2025)
9.4 Latin America Human Coagulation Factor Ⅷ Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Coagulation Factor Ⅷ Market Size (2020-2031)
10.2 Middle East & Africa Human Coagulation Factor Ⅷ Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country (2020-2025)
10.4 Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Human Coagulation Factor Ⅷ Introduction
11.1.4 Bayer Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.1.5 Bayer Recent Development
11.2 CSL Behring
11.2.1 CSL Behring Company Details
11.2.2 CSL Behring Business Overview
11.2.3 CSL Behring Human Coagulation Factor Ⅷ Introduction
11.2.4 CSL Behring Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.2.5 CSL Behring Recent Development
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter Human Coagulation Factor Ⅷ Introduction
11.3.4 Baxter Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.3.5 Baxter Recent Development
11.4 Grifols
11.4.1 Grifols Company Details
11.4.2 Grifols Business Overview
11.4.3 Grifols Human Coagulation Factor Ⅷ Introduction
11.4.4 Grifols Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.4.5 Grifols Recent Development
11.5 Octapharma
11.5.1 Octapharma Company Details
11.5.2 Octapharma Business Overview
11.5.3 Octapharma Human Coagulation Factor Ⅷ Introduction
11.5.4 Octapharma Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.5.5 Octapharma Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Human Coagulation Factor Ⅷ Introduction
11.6.4 Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.6.5 Pfizer Recent Development
11.7 Taibang Bio
11.7.1 Taibang Bio Company Details
11.7.2 Taibang Bio Business Overview
11.7.3 Taibang Bio Human Coagulation Factor Ⅷ Introduction
11.7.4 Taibang Bio Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.7.5 Taibang Bio Recent Development
11.8 Shanghai Laishi
11.8.1 Shanghai Laishi Company Details
11.8.2 Shanghai Laishi Business Overview
11.8.3 Shanghai Laishi Human Coagulation Factor Ⅷ Introduction
11.8.4 Shanghai Laishi Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.8.5 Shanghai Laishi Recent Development
11.9 Hualan Bio
11.9.1 Hualan Bio Company Details
11.9.2 Hualan Bio Business Overview
11.9.3 Hualan Bio Human Coagulation Factor Ⅷ Introduction
11.9.4 Hualan Bio Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.9.5 Hualan Bio Recent Development
11.10 Guangdong Shuanglin
11.10.1 Guangdong Shuanglin Company Details
11.10.2 Guangdong Shuanglin Business Overview
11.10.3 Guangdong Shuanglin Human Coagulation Factor Ⅷ Introduction
11.10.4 Guangdong Shuanglin Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.10.5 Guangdong Shuanglin Recent Development
11.11 GreenCross
11.11.1 GreenCross Company Details
11.11.2 GreenCross Business Overview
11.11.3 GreenCross Human Coagulation Factor Ⅷ Introduction
11.11.4 GreenCross Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.11.5 GreenCross Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Human Coagulation Factor Ⅷ Introduction
11.12.4 Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2020-2025)
11.12.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Recombinant Factor VIII
Table 3. Key Players of Human Factor VIII
Table 4. Global Human Coagulation Factor Ⅷ Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Human Coagulation Factor Ⅷ Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Human Coagulation Factor Ⅷ Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Human Coagulation Factor Ⅷ Market Share by Region (2020-2025)
Table 8. Global Human Coagulation Factor Ⅷ Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Human Coagulation Factor Ⅷ Market Share by Region (2026-2031)
Table 10. Human Coagulation Factor Ⅷ Market Trends
Table 11. Human Coagulation Factor Ⅷ Market Drivers
Table 12. Human Coagulation Factor Ⅷ Market Challenges
Table 13. Human Coagulation Factor Ⅷ Market Restraints
Table 14. Global Human Coagulation Factor Ⅷ Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Human Coagulation Factor Ⅷ Market Share by Players (2020-2025)
Table 16. Global Top Human Coagulation Factor Ⅷ Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor Ⅷ as of 2024)
Table 17. Ranking of Global Top Human Coagulation Factor Ⅷ Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Human Coagulation Factor Ⅷ Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Human Coagulation Factor Ⅷ, Headquarters and Area Served
Table 20. Global Key Players of Human Coagulation Factor Ⅷ, Product and Application
Table 21. Global Key Players of Human Coagulation Factor Ⅷ, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Coagulation Factor Ⅷ Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Human Coagulation Factor Ⅷ Revenue Market Share by Type (2020-2025)
Table 25. Global Human Coagulation Factor Ⅷ Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Human Coagulation Factor Ⅷ Revenue Market Share by Type (2026-2031)
Table 27. Global Human Coagulation Factor Ⅷ Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Human Coagulation Factor Ⅷ Revenue Market Share by Application (2020-2025)
Table 29. Global Human Coagulation Factor Ⅷ Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Human Coagulation Factor Ⅷ Revenue Market Share by Application (2026-2031)
Table 31. North America Human Coagulation Factor Ⅷ Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Human Coagulation Factor Ⅷ Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Human Coagulation Factor Ⅷ Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Human Coagulation Factor Ⅷ Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Human Coagulation Factor Ⅷ Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Human Coagulation Factor Ⅷ Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Human Coagulation Factor Ⅷ Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Coagulation Factor Ⅷ Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Human Coagulation Factor Ⅷ Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Human Coagulation Factor Ⅷ Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Human Coagulation Factor Ⅷ Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bayer Company Details
Table 47. Bayer Business Overview
Table 48. Bayer Human Coagulation Factor Ⅷ Product
Table 49. Bayer Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 50. Bayer Recent Development
Table 51. CSL Behring Company Details
Table 52. CSL Behring Business Overview
Table 53. CSL Behring Human Coagulation Factor Ⅷ Product
Table 54. CSL Behring Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 55. CSL Behring Recent Development
Table 56. Baxter Company Details
Table 57. Baxter Business Overview
Table 58. Baxter Human Coagulation Factor Ⅷ Product
Table 59. Baxter Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 60. Baxter Recent Development
Table 61. Grifols Company Details
Table 62. Grifols Business Overview
Table 63. Grifols Human Coagulation Factor Ⅷ Product
Table 64. Grifols Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 65. Grifols Recent Development
Table 66. Octapharma Company Details
Table 67. Octapharma Business Overview
Table 68. Octapharma Human Coagulation Factor Ⅷ Product
Table 69. Octapharma Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 70. Octapharma Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Human Coagulation Factor Ⅷ Product
Table 74. Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Taibang Bio Company Details
Table 77. Taibang Bio Business Overview
Table 78. Taibang Bio Human Coagulation Factor Ⅷ Product
Table 79. Taibang Bio Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 80. Taibang Bio Recent Development
Table 81. Shanghai Laishi Company Details
Table 82. Shanghai Laishi Business Overview
Table 83. Shanghai Laishi Human Coagulation Factor Ⅷ Product
Table 84. Shanghai Laishi Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 85. Shanghai Laishi Recent Development
Table 86. Hualan Bio Company Details
Table 87. Hualan Bio Business Overview
Table 88. Hualan Bio Human Coagulation Factor Ⅷ Product
Table 89. Hualan Bio Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 90. Hualan Bio Recent Development
Table 91. Guangdong Shuanglin Company Details
Table 92. Guangdong Shuanglin Business Overview
Table 93. Guangdong Shuanglin Human Coagulation Factor Ⅷ Product
Table 94. Guangdong Shuanglin Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 95. Guangdong Shuanglin Recent Development
Table 96. GreenCross Company Details
Table 97. GreenCross Business Overview
Table 98. GreenCross Human Coagulation Factor Ⅷ Product
Table 99. GreenCross Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 100. GreenCross Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Human Coagulation Factor Ⅷ Product
Table 104. Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Human Coagulation Factor Ⅷ Picture
Figure 2. Global Human Coagulation Factor Ⅷ Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Coagulation Factor Ⅷ Market Share by Type: 2024 VS 2031
Figure 4. Recombinant Factor VIII Features
Figure 5. Human Factor VIII Features
Figure 6. Global Human Coagulation Factor Ⅷ Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Human Coagulation Factor Ⅷ Market Share by Application: 2024 VS 2031
Figure 8. Hemophilia A Case Studies
Figure 9. Relvent Bleeding Diseases Case Studies
Figure 10. Human Coagulation Factor Ⅷ Report Years Considered
Figure 11. Global Human Coagulation Factor Ⅷ Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Human Coagulation Factor Ⅷ Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Coagulation Factor Ⅷ Market Share by Region: 2024 VS 2031
Figure 14. Global Human Coagulation Factor Ⅷ Market Share by Players in 2024
Figure 15. Global Top Human Coagulation Factor Ⅷ Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor Ⅷ as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Human Coagulation Factor Ⅷ Revenue in 2024
Figure 17. North America Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Human Coagulation Factor Ⅷ Market Share by Country (2020-2031)
Figure 19. United States Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Human Coagulation Factor Ⅷ Market Share by Country (2020-2031)
Figure 23. Germany Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Human Coagulation Factor Ⅷ Market Share by Region (2020-2031)
Figure 31. China Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Human Coagulation Factor Ⅷ Market Share by Country (2020-2031)
Figure 39. Mexico Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Human Coagulation Factor Ⅷ Market Share by Country (2020-2031)
Figure 43. Turkey Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Bayer Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 47. CSL Behring Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 48. Baxter Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 49. Grifols Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 50. Octapharma Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 52. Taibang Bio Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 53. Shanghai Laishi Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 54. Hualan Bio Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 55. Guangdong Shuanglin Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 56. GreenCross Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 57. Pfizer Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Recombinant Factor VIII
Table 3. Key Players of Human Factor VIII
Table 4. Global Human Coagulation Factor Ⅷ Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Human Coagulation Factor Ⅷ Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Human Coagulation Factor Ⅷ Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Human Coagulation Factor Ⅷ Market Share by Region (2020-2025)
Table 8. Global Human Coagulation Factor Ⅷ Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Human Coagulation Factor Ⅷ Market Share by Region (2026-2031)
Table 10. Human Coagulation Factor Ⅷ Market Trends
Table 11. Human Coagulation Factor Ⅷ Market Drivers
Table 12. Human Coagulation Factor Ⅷ Market Challenges
Table 13. Human Coagulation Factor Ⅷ Market Restraints
Table 14. Global Human Coagulation Factor Ⅷ Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Human Coagulation Factor Ⅷ Market Share by Players (2020-2025)
Table 16. Global Top Human Coagulation Factor Ⅷ Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor Ⅷ as of 2024)
Table 17. Ranking of Global Top Human Coagulation Factor Ⅷ Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Human Coagulation Factor Ⅷ Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Human Coagulation Factor Ⅷ, Headquarters and Area Served
Table 20. Global Key Players of Human Coagulation Factor Ⅷ, Product and Application
Table 21. Global Key Players of Human Coagulation Factor Ⅷ, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Coagulation Factor Ⅷ Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Human Coagulation Factor Ⅷ Revenue Market Share by Type (2020-2025)
Table 25. Global Human Coagulation Factor Ⅷ Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Human Coagulation Factor Ⅷ Revenue Market Share by Type (2026-2031)
Table 27. Global Human Coagulation Factor Ⅷ Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Human Coagulation Factor Ⅷ Revenue Market Share by Application (2020-2025)
Table 29. Global Human Coagulation Factor Ⅷ Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Human Coagulation Factor Ⅷ Revenue Market Share by Application (2026-2031)
Table 31. North America Human Coagulation Factor Ⅷ Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Human Coagulation Factor Ⅷ Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Human Coagulation Factor Ⅷ Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Human Coagulation Factor Ⅷ Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Human Coagulation Factor Ⅷ Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Human Coagulation Factor Ⅷ Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Human Coagulation Factor Ⅷ Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Coagulation Factor Ⅷ Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Human Coagulation Factor Ⅷ Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Human Coagulation Factor Ⅷ Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Human Coagulation Factor Ⅷ Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bayer Company Details
Table 47. Bayer Business Overview
Table 48. Bayer Human Coagulation Factor Ⅷ Product
Table 49. Bayer Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 50. Bayer Recent Development
Table 51. CSL Behring Company Details
Table 52. CSL Behring Business Overview
Table 53. CSL Behring Human Coagulation Factor Ⅷ Product
Table 54. CSL Behring Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 55. CSL Behring Recent Development
Table 56. Baxter Company Details
Table 57. Baxter Business Overview
Table 58. Baxter Human Coagulation Factor Ⅷ Product
Table 59. Baxter Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 60. Baxter Recent Development
Table 61. Grifols Company Details
Table 62. Grifols Business Overview
Table 63. Grifols Human Coagulation Factor Ⅷ Product
Table 64. Grifols Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 65. Grifols Recent Development
Table 66. Octapharma Company Details
Table 67. Octapharma Business Overview
Table 68. Octapharma Human Coagulation Factor Ⅷ Product
Table 69. Octapharma Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 70. Octapharma Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Human Coagulation Factor Ⅷ Product
Table 74. Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Taibang Bio Company Details
Table 77. Taibang Bio Business Overview
Table 78. Taibang Bio Human Coagulation Factor Ⅷ Product
Table 79. Taibang Bio Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 80. Taibang Bio Recent Development
Table 81. Shanghai Laishi Company Details
Table 82. Shanghai Laishi Business Overview
Table 83. Shanghai Laishi Human Coagulation Factor Ⅷ Product
Table 84. Shanghai Laishi Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 85. Shanghai Laishi Recent Development
Table 86. Hualan Bio Company Details
Table 87. Hualan Bio Business Overview
Table 88. Hualan Bio Human Coagulation Factor Ⅷ Product
Table 89. Hualan Bio Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 90. Hualan Bio Recent Development
Table 91. Guangdong Shuanglin Company Details
Table 92. Guangdong Shuanglin Business Overview
Table 93. Guangdong Shuanglin Human Coagulation Factor Ⅷ Product
Table 94. Guangdong Shuanglin Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 95. Guangdong Shuanglin Recent Development
Table 96. GreenCross Company Details
Table 97. GreenCross Business Overview
Table 98. GreenCross Human Coagulation Factor Ⅷ Product
Table 99. GreenCross Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 100. GreenCross Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Human Coagulation Factor Ⅷ Product
Table 104. Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2020-2025) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Human Coagulation Factor Ⅷ Picture
Figure 2. Global Human Coagulation Factor Ⅷ Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Coagulation Factor Ⅷ Market Share by Type: 2024 VS 2031
Figure 4. Recombinant Factor VIII Features
Figure 5. Human Factor VIII Features
Figure 6. Global Human Coagulation Factor Ⅷ Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Human Coagulation Factor Ⅷ Market Share by Application: 2024 VS 2031
Figure 8. Hemophilia A Case Studies
Figure 9. Relvent Bleeding Diseases Case Studies
Figure 10. Human Coagulation Factor Ⅷ Report Years Considered
Figure 11. Global Human Coagulation Factor Ⅷ Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Human Coagulation Factor Ⅷ Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Coagulation Factor Ⅷ Market Share by Region: 2024 VS 2031
Figure 14. Global Human Coagulation Factor Ⅷ Market Share by Players in 2024
Figure 15. Global Top Human Coagulation Factor Ⅷ Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor Ⅷ as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Human Coagulation Factor Ⅷ Revenue in 2024
Figure 17. North America Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Human Coagulation Factor Ⅷ Market Share by Country (2020-2031)
Figure 19. United States Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Human Coagulation Factor Ⅷ Market Share by Country (2020-2031)
Figure 23. Germany Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Human Coagulation Factor Ⅷ Market Share by Region (2020-2031)
Figure 31. China Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Human Coagulation Factor Ⅷ Market Share by Country (2020-2031)
Figure 39. Mexico Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Human Coagulation Factor Ⅷ Market Share by Country (2020-2031)
Figure 43. Turkey Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Human Coagulation Factor Ⅷ Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Bayer Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 47. CSL Behring Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 48. Baxter Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 49. Grifols Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 50. Octapharma Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 52. Taibang Bio Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 53. Shanghai Laishi Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 54. Hualan Bio Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 55. Guangdong Shuanglin Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 56. GreenCross Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 57. Pfizer Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232